BBVA USA’s CME Group CME Stock Holding History

BBVA USA’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$118K	Buy	608 +107	+21%	+$21.7K	0.01%	519
2021 Q2	$107K	Buy	+501	New	+$106K	0.01%	551

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BBVA USA's CME Position: Q3 2021 in Review

BBVA USA increased its CME Group (CME) stake by 21% in Q3 2021, buying an estimated $21.7K and bringing the position to 608 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #519.

BBVA USA first reported a position in CME in Q2 2021 and has held it in 2 quarters since. 1,054 funds tracked by Wall St. Rank hold CME as of Q3 2021.

BBVA USA held 608 shares of CME Group worth $118K as of Q3 2021.
BBVA USA bought 107 CME Group shares in Q3 2021, an estimated $21.7K.
CME Group made up 0.01% of BBVA USA's portfolio in Q3 2021, its #519 holding.
BBVA USA first reported a position in CME Group in Q2 2021 and has held it in 2 quarters since.
1,054 funds tracked by Wall St. Rank held CME Group as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.